Party Drug Ecstasy May Cause More Widespread Brain Damage Than Previously Thought















Share on Tumblr

dopamine

Image: SCIENCE

  • The Wisdom of Psychopaths

    In this engrossing journey into the lives of psychopaths and their infamously crafty behaviors, the renowned psychologist Kevin Dutton reveals that there is a...

    Read More »

Raising new concerns about use of the popular recreational drug ecstasy, or MDMA, scientists have found that just a few doses of the substance causes extensive damage to brain cells in monkeys. The findings, published today in the journal Science, suggest that using ecstasy may increase the risk of developing Parkinsonism--a condition similar to Parkinson's disease--later in life.

Earlier animal studies had shown that repeated ecstasy use damages the serotonin brain cells, which help to regulate mood and behavior. In the new work, Johns Hopkins University researchers working with squirrel monkeys and baboons found that two or three sequential doses of the drug--the amount typically taken by young adults at all-night "raves"--killed dopamine neurons, which are involved in controlling movement, emotional and cognitive responses and the ability to feel pleasure. Indeed, some 60 to 80 percent of the dopaminergic nerve endings in a region of the brain known as the striatum were destroyed after just one multi-dose regimen. (In the image above, the depletion of dopamine binding sites is indicated by the increase in blues and greens seen in the scan on the right compared to the one on the left.)

In humans, once damage to these nerve endings crosses a certain threshold, leading to an 80 to 90 percent loss of brain dopamine, Parkinsonism typically occurs. If ecstasy damages dopamine neurons in humans the way it does in monkeys, team member George A. Ricaurte says, Parkinsonism could develop years after taking the drug because brain dopamine declines with age. "The message seems clear," he adds. "The neurotoxic potential of MDMA is high, and use of several sequential recreational doses could have serious, long-term consequences."



1 Comments

Add Comment
View
  1. 1. chemmandream 08:50 AM 5/1/13

    Im not proud of this but, i have taken over 3000 xtc pills since I was 17 im now 23 but i quit at 22. I am a straight A student. In my masters program for chemistry. have no neurological effects for the abuse. Also i wasn't
    just on MDMA. I was on a varity of other drugs too. Such as LSD about 180 trips of that. 100 trips of mesculine.
    heroin u name it iv done it, but iv been clean for a year now an i don't notice any negitive affects at all.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

Follow Us:

See what we're tweeting about

Scientific American MIND

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital

Latest from SA Blog Network

  SA Digital

Science Jobs of the Week

Email this Article

Party Drug Ecstasy May Cause More Widespread Brain Damage Than Previously Thought

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X